Ophthalmic Devices - Fiji | Statista Market Forecast

The Ophthalmic Devices market market in Fiji is anticipated to achieve a revenue of US$2.11m in the year 2024.
It is projected to experience a steady annual growth rate (CAGR 2024-2029) of 5.96%, leading to a market volume of US$2.82m by 2029.
When compared globally, the United States is expected to generate the highest revenue of US$14.00bn in the year 2024.
Fiji's ophthalmic devices market is witnessing an increase in demand due to the rising prevalence of eye diseases and a growing elderly population.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in Fiji is experiencing steady growth and development. Customer preferences in the Ophthalmic Devices market in Fiji are influenced by several factors. Firstly, there is a growing awareness and concern about eye health among the population. As a result, there is an increasing demand for ophthalmic devices such as glasses, contact lenses, and surgical instruments. Customers are looking for products that can improve their vision and enhance their overall eye health. Another customer preference in Fiji is affordability. The majority of the population in Fiji has limited financial resources, and therefore, they seek ophthalmic devices that are cost-effective and provide value for money. Customers are more likely to purchase products that offer good quality at a reasonable price. Trends in the Ophthalmic Devices market in Fiji are influenced by global and regional market trends. One of the key trends is the increasing prevalence of eye disorders and diseases. With the aging population and changing lifestyles, the incidence of eye-related problems such as cataracts, glaucoma, and refractive errors is on the rise. This has led to a higher demand for ophthalmic devices that can diagnose, treat, and manage these conditions. Another trend in the market is the advancement in technology. Ophthalmic devices are becoming more sophisticated and innovative, offering better accuracy, comfort, and convenience. Customers in Fiji are increasingly looking for products that incorporate the latest technology to improve their visual experience. Local special circumstances in Fiji also play a role in the development of the Ophthalmic Devices market. The geographical location of Fiji, as an island nation in the South Pacific, poses challenges in terms of accessibility and distribution of ophthalmic devices. However, advancements in logistics and transportation have made it easier for manufacturers to reach customers in remote areas. Underlying macroeconomic factors are also contributing to the growth of the Ophthalmic Devices market in Fiji. The steady economic growth and increasing disposable income in the country have resulted in higher healthcare spending. This has created a favorable environment for the development and expansion of the ophthalmic devices market. In conclusion, the Ophthalmic Devices market in Fiji is experiencing growth and development driven by customer preferences, global and regional market trends, local special circumstances, and underlying macroeconomic factors. The increasing awareness about eye health, affordability, prevalence of eye disorders, technological advancements, and economic growth are all contributing to the expansion of the market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.